<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30275860</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>05</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Print">1738-6756</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>21</Volume>                    <Issue>3</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Journal of breast cancer</Title>                <ISOAbbreviation>J Breast Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Evaluating the Prediction of Breast Cancer Survival Using Lymph Node Ratio.</ArticleTitle>            <Pagination>                <MedlinePgn>315-320</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.4048/jbc.2018.21.e35</ELocationID>            <Abstract>                <AbstractText Label="Purpose" NlmCategory="UNASSIGNED">Previous oncological studies showed that lymph node ratio (LNR) (ratio of number of lymph nodes that tested positive for metastasis to the total number of lymph nodes examined) is a negative indicator of cancer survival. The American Joint Committee on Cancer (AJCC) staging system incorporates tumor size, lymph node involvement, and metastasis in a comprehensive model of cancer progression, but LNR alone has been shown to outperform the AJCC system in prognostic and survival predictions for various types of cancer. The effectiveness of LNR has not been evaluated in breast cancer staging. Evaluating LNR for predicting cancer staging in breast cancer has the potential to improve treatment recommendations.</AbstractText>                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">The Surveillance, Epidemiology, and End Results dataset was used to identify 10,655 breast cancer patients who underwent nodal evaluation from 2010 to 2013, and their LNRs were calculated. Descriptive statistics of lymph node evaluation in the patients are provided. Logistic regression with LNR as the continuous independent variable was conducted to determine whether LNR could predict cancer progression, coded as regional or distant. Analysis was conducted using SPSS version 24.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Patient's mean age was 59.43Â±18.62. Logistic regression analysis revealed that for every 1.3% increase in LNR, the odds of falling into the distant stage of the TNM staging system increased by 13.7% (odds ratio, 14.73; 95% confidence interval, 12.00-18.08).</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">LNR, while correlated with breast cancer staging, serves as a better predictor of survival. Precision staging can influence treatment modality, and improved treatments can significantly improve quality of life. Additional research and diagnostic examinations using LNR as a potential tool for accurate staging in breast cancer patients are warranted.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Hung</LastName>                    <ForeName>Man</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Orthopaedics, University of Utah School of Medicine, Salt Lake City, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Study Design and Biostatistics Center, University of Utah School of Medicine, Salt Lake City, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Huntsman Cancer Institute, University of Utah, Salt Lake City, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Xu</LastName>                    <ForeName>Julie</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Orthopaedics, University of Utah School of Medicine, Salt Lake City, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nielson</LastName>                    <ForeName>Dominique</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Orthopaedics, University of Utah School of Medicine, Salt Lake City, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bounsanga</LastName>                    <ForeName>Jerry</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Orthopaedics, University of Utah School of Medicine, Salt Lake City, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gu</LastName>                    <ForeName>Yushan</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Orthopaedics, University of Utah School of Medicine, Salt Lake City, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hansen</LastName>                    <ForeName>Alec Roger</ForeName>                    <Initials>AR</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Orthopaedics, University of Utah School of Medicine, Salt Lake City, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Voss</LastName>                    <ForeName>Maren Wright</ForeName>                    <Initials>MW</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Orthopaedics, University of Utah School of Medicine, Salt Lake City, USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>UL1 TR001067</GrantID>                    <Acronym>TR</Acronym>                    <Agency>NCATS NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>28</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Korea (South)</Country>            <MedlineTA>J Breast Cancer</MedlineTA>            <NlmUniqueID>101314183</NlmUniqueID>            <ISSNLinking>1738-6756</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer. 2018 May;25(3):315-324</RefSource>                <PMID Version="1">29353447</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):619-626</RefSource>                <PMID Version="1">29593010</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Cancer Res. 2015 Jan 15;5(2):844-53</RefSource>                <PMID Version="1">25973321</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Surg Oncol. 2017 Apr;43(4):743-750</RefSource>                <PMID Version="1">28094085</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Clin Oncol. 2017 Oct;14(10):595-610</RefSource>                <PMID Version="1">28561071</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomark Cancer. 2013 Oct 29;5:61-70</RefSource>                <PMID Version="1">24250234</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer. 2014 Jan;21(1):1-9</RefSource>                <PMID Version="1">24101545</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Surg Oncol. 2015 Jun;24(2):84-8</RefSource>                <PMID Version="1">25912951</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Surg Oncol. 2015 Feb 07;13:33</RefSource>                <PMID Version="1">25889186</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2012 Jun;19(6):1808-17</RefSource>                <PMID Version="1">22207051</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2006 Jun 20;24(18):2910-6</RefSource>                <PMID Version="1">16782931</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2003 Aug 1;21(15):2912-9</RefSource>                <PMID Version="1">12885809</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Future Oncol. 2009 Dec;5(10):1585-603</RefSource>                <PMID Version="1">20001797</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2017 Oct;165(3):743-750</RefSource>                <PMID Version="1">28689363</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2017 Jul 8;67(4):290-303</RefSource>                <PMID Version="1">28294295</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2015 Mar 30;107(6):djv048</RefSource>                <PMID Version="1">25825511</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2010 Jun;17(6):1471-4</RefSource>                <PMID Version="1">20180029</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2008 Jun;15(6):1600-8</RefSource>                <PMID Version="1">18327530</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2015 Oct 20;314(15):1599-614</RefSource>                <PMID Version="1">26501536</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncologist. 2017 Nov;22(11):1292-1300</RefSource>                <PMID Version="1">28592619</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30</RefSource>                <PMID Version="1">26742998</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J BUON. 2015 May-Jun;20(3):737-45</RefSource>                <PMID Version="1">26214625</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2016 Oct;23(10):3310-6</RefSource>                <PMID Version="1">27401442</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Clin Oncol. 2017 Feb;40(1):35-41</RefSource>                <PMID Version="1">25089533</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Virchows Arch. 2018 Feb;472(2):195-203</RefSource>                <PMID Version="1">28825136</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Surgery. 2007 May;141(5):610-8</RefSource>                <PMID Version="1">17462460</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">American Joint Committee on Cancer</Keyword>            <Keyword MajorTopicYN="N">Breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">Lymph node</Keyword>            <Keyword MajorTopicYN="N">Neoplasm staging</Keyword>            <Keyword MajorTopicYN="N">Survival</Keyword>        </KeywordList>        <CoiStatement>CONFLICT OF INTEREST: The authors declare that they have no competing interests.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>03</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>04</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30275860</ArticleId>            <ArticleId IdType="doi">10.4048/jbc.2018.21.e35</ArticleId>            <ArticleId IdType="pmc">PMC6158156</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>